HSIC
Price
$70.60
Change
-$0.60 (-0.84%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
8.31B
91 days until earnings call
Intraday BUY SELL Signals
SHTDY
Price
$13.19
Change
-$0.26 (-1.93%)
Updated
Nov 18 closing price
Capitalization
8.21B
Intraday BUY SELL Signals
Interact to see
Advertisement

HSIC vs SHTDY

Header iconHSIC vs SHTDY Comparison
Open Charts HSIC vs SHTDYBanner chart's image
Henry Schein
Price$70.60
Change-$0.60 (-0.84%)
Volume$10.86K
Capitalization8.31B
Sinopharm Group
Price$13.19
Change-$0.26 (-1.93%)
Volume$21.1K
Capitalization8.21B
HSIC vs SHTDY Comparison Chart in %
HSIC
Daily Signal:
Gain/Loss:
SHTDY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HSIC vs. SHTDY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Hold and SHTDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (HSIC: $71.19 vs. SHTDY: $13.19)
Brand notoriety: HSIC and SHTDY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 88% vs. SHTDY: 47%
Market capitalization -- HSIC: $8.31B vs. SHTDY: $8.19B
HSIC [@Medical Distributors] is valued at $8.31B. SHTDY’s [@Medical Distributors] market capitalization is $8.19B. The market cap for tickers in the [@Medical Distributors] industry ranges from $105.22B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileSHTDY’s FA Score has 2 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • SHTDY’s FA Score: 2 green, 3 red.
According to our system of comparison, SHTDY is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 5 TA indicator(s) are bullish while SHTDY’s TA Score has 4 bullish TA indicator(s).

  • HSIC’s TA Score: 5 bullish, 5 bearish.
  • SHTDY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SHTDY is a better buy in the short-term than HSIC.

Price Growth

HSIC (@Medical Distributors) experienced а -2.77% price change this week, while SHTDY (@Medical Distributors) price change was -1.86% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -2.48%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was -0.09%.

Reported Earning Dates

HSIC is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Medical Distributors (-2.48% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HSIC($8.31B) and SHTDY($8.21B) have the same market capitalization . HSIC has higher P/E ratio than SHTDY: HSIC (22.27) vs SHTDY (8.59). HSIC YTD gains are higher at: 2.876 vs. SHTDY (1.136). SHTDY has higher annual earnings (EBITDA): 21.5B vs. HSIC (932M). SHTDY has higher revenues than HSIC: SHTDY (585B) vs HSIC (12.8B).
HSICSHTDYHSIC / SHTDY
Capitalization8.31B8.21B101%
EBITDA932M21.5B4%
Gain YTD2.8761.136253%
P/E Ratio22.278.59259%
Revenue12.8B585B2%
Total Cash145MN/A-
Total Debt3.36BN/A-
FUNDAMENTALS RATINGS
HSIC vs SHTDY: Fundamental Ratings
HSIC
SHTDY
OUTLOOK RATING
1..100
2323
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
8658
SMR RATING
1..100
65100
PRICE GROWTH RATING
1..100
4845
P/E GROWTH RATING
1..100
7521
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDY's Valuation (28) in the null industry is somewhat better than the same rating for HSIC (74) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than HSIC’s over the last 12 months.

SHTDY's Profit vs Risk Rating (58) in the null industry is in the same range as HSIC (86) in the Medical Distributors industry. This means that SHTDY’s stock grew similarly to HSIC’s over the last 12 months.

HSIC's SMR Rating (65) in the Medical Distributors industry is somewhat better than the same rating for SHTDY (100) in the null industry. This means that HSIC’s stock grew somewhat faster than SHTDY’s over the last 12 months.

SHTDY's Price Growth Rating (45) in the null industry is in the same range as HSIC (48) in the Medical Distributors industry. This means that SHTDY’s stock grew similarly to HSIC’s over the last 12 months.

SHTDY's P/E Growth Rating (21) in the null industry is somewhat better than the same rating for HSIC (75) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICSHTDY
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
50%
Bullish Trend 8 days ago
65%
Declines
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
HSIC
Daily Signal:
Gain/Loss:
SHTDY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADCIX26.42N/A
N/A
American Century Disciplined Growth I
ANONX23.45N/A
N/A
American Century Small Cap Growth I
TFFIX83.12N/A
N/A
Touchstone Focused Instl
PMARX12.56N/A
N/A
Victory Pioneer Equ Premium Income A
VSMPX298.14N/A
N/A
Vanguard Total Stock Mkt Idx Instl Pls

SHTDY and

Correlation & Price change

A.I.dvisor tells us that SHTDY and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDY and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDY
1D Price
Change %
SHTDY100%
-1.93%
YI - SHTDY
21%
Poorly correlated
+0.04%
SHTDF - SHTDY
19%
Poorly correlated
N/A
HSIC - SHTDY
11%
Poorly correlated
-0.08%
ZYXI - SHTDY
9%
Poorly correlated
-25.68%
OMI - SHTDY
6%
Poorly correlated
N/A
More